Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
12.69
+0.44 (3.59%)
Dec 15, 2025, 10:35 AM EST - Market open
Daxor Market Cap
Daxor has a market cap or net worth of $63.25 million as of December 15, 2025. Its market cap has increased by 45.05% in one year.
Market Cap
63.25M
Enterprise Value
61.32M
1-Year Change
45.05%
Ranking
Category
Stock Price
$12.69
Market Cap Chart
Since September 3, 1985, Daxor's market cap has increased from $30.27M to $63.25M, an increase of 108.98%. That is a compound annual growth rate of 1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 61.06M | 64.05% |
| Dec 31, 2024 | 37.22M | -19.10% |
| Dec 29, 2023 | 46.01M | 17.82% |
| Dec 30, 2022 | 39.05M | -14.22% |
| Dec 31, 2021 | 45.52M | -6.35% |
| Dec 31, 2020 | 48.61M | 38.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |